Skip to content
AGENCY: Healthcare Demand Generation
Apply free

Patient Product Marketing › Direct-to-Patient

The compliant patient acquisition system, built legal-first.

Patient marketing can mean anything from patient experience to trial recruitment, but we do one thing: build patient demand for your product. For a prescription-only medicine, where the law rules that out, we build awareness of the condition instead. Patients now research treatments online before any clinic appointment is booked. UK private healthcare admissions hit record highs in 2023, with self-pay at its highest ever level (PHIN). The clinical-only buyer model assumed they wouldn't be searching. That assumption is now expensive. AGENCY builds the legal framework first, then the messaging, campaigns, and proof - so the compliance team becomes the enabler, not the blocker.

Apply for a free 60 minutes with usDownload the Patient Marketing Framework
Senior patient researching her treatment options - direct-to-patient marketing in healthcare

Live proof from the case studies

285 enquiries

in one month across three markets. Every form routed to a clinic, tracked and reported by country.

Medical device · International

Read the case study →

128 UK referrals

in a single month at £18.66 CPA. 157% uplift in conversions vs prior period.

nSTRIDE · Zimmer Biomet

Read the case study →

Does this sound familiar?

The Invisible Product

Patients are having a product fitted or used, and they've never heard of the manufacturer. The clinician chose. The patient went along with it. The brand doesn't exist to the person who benefits most.

The Compliance Wall

Patient marketing has come up in planning meetings. Legal said no. Or nobody could explain what's allowed. The idea dies, and comes back six months later, no further forward.

The Clinic Bottleneck

Revenue depends on patients arriving at clinics that use the product. Companies in this position have zero influence over how many patients walk through the door - and total dependency on the clinician's referral network.

The Self-Pay Blindspot

UK private healthcare admissions hit record highs in 2023 (PHIN). Self-pay reached its highest ever level. Patients are paying out of pocket and choosing their own providers. Invisible to them means invisible at the moment the choice gets made.

Patient marketing only pays back when you've diagnosed the right problem.

Before any patient marketing investment, the question worth asking is what kind of problem the business actually has. If commercial numbers are missing target, the cause is usually one of three things: (a) reps aren't closing the conversations they're in; (b) reps aren't getting the conversations they need; or (c) the patient isn't asking for you at the clinic. Only the third is a patient marketing problem.

Most healthcare companies misdiagnose (c) as (a) or (b) - and spend on sales fixes that don't move anything. The book this agency was built around ("It's Not a Sales Problem") names this failure mode directly. Patient marketing isn't a tactic; it's the demand-layer fix for businesses whose patients can't ask for them by name.

Once the diagnosis is right, the constraint isn't whether patient marketing is a good idea - it's the regulatory complexity. ABPI, ASA, MHRA, MDR. Most companies leave money on the table because complexity without expertise produces paralysis. The fix isn't ignoring regulation. It's having someone who understands it deeply enough to build compliant frameworks that actually work.

The permission problem: most companies aren't blocked from patient marketing. They've assumed they are.

Legal first. Then messaging, campaigns, and proof.

Four layers. The sequence matters. Without the legal unlock, nothing else is viable.

01

The Legal Unlock

The primary differentiator. Before any creative work begins, the compliance framework gets built. Legal assessment. Claims matrix. Documentation trail. Co-marketing structure with clear legal footing. The founder has a law degree, has worked with the world's largest legal firms, and has built patient marketing frameworks for global pharma. The legal team is engaged with, not worked around.

02

Research-Backed Messaging

Patient communication is fundamentally different from HCP communication. What motivates patients, how they process health information, what barriers prevent them seeking treatment - this requires research, not assumptions. The agency's partnership with Professor Christopher Eccleston and the Centre for Pain Research at University of Bath provides peer-reviewed insight into how patients make health decisions.

03

Campaigns That Reach Patients

Knowing what to say legally and knowing how to reach patients are different skills. Both are required. Direct-to-patient digital campaigns get built and run: SEO, paid search, social, patient content, condition-specific guides, and find-a-clinic functionality that connects patients to appropriate providers.

What you walk away with.

Legal Framework

Compliant structure for direct patient campaigns. What's allowed, what isn't, with evidence links. Your regulatory team signs off before creative begins.

Claims Matrix

Every patient-facing claim mapped to evidence. Built with your regulatory team. MLR-ready from day one.

Patient Content Strategy

Research-informed content plan. Condition-specific guides, recovery materials, video scripts. Built on peer-reviewed research, not assumptions.

Digital Campaign Infrastructure

SEO, paid search, social campaigns. Targeting patients searching for conditions your products address. Built, launched, and optimised.

Find-a-Clinic Functionality

Connect searching patients to clinics that use your products. The bridge between patient demand and your customer network.

Performance Dashboard

Real-time performance data. Traffic, enquiries, conversions, cost per enquiry, attribution. Board-ready reporting that proves return.

Real campaigns. Real numbers.

International · Enterprise

Medical device company · international patient acquisition

Problem

A novel non-surgical treatment with low patient awareness in three European target markets, each with different patient profiles, regulatory standards, and private-pay dynamics. The clinical case was strong. The patient acquisition system did not yet exist.

What we did

Patient persona development. Compliant messaging in each market. Three persona-matched patient films. Meta paid social at scale. Per-market performance tracking. The system was designed to scale to new markets on the same infrastructure.

Result

285 patient enquiries in one month across three markets, each a completed form routed to a clinic. Every market on its own dashboard with country-level reporting, and the creative, targeting and budget adjusted on the data each month.

Read the full case study →

Single market · Enterprise

nSTRIDE · Zimmer Biomet

Problem

A treatment gap running roughly fifty to sixty-nine, where patients are too young for a replacement and past what conservative care holds. A non-surgical treatment most of them had never heard of. Existing materials written for surgeons, not patients. GPs were defaulting to the wrong referral pathway because they did not know an option existed.

What we did

Five patient personas. Compliant patient-facing messaging through the Centre for Pain Research at the University of Bath. Find-a-Clinic locator. Tracked landing pages per clinic. Paid search targeted by symptom and geography. National PR including a Daily Mail feature.

Result

128 UK clinic referrals from the Find a Clinic page in a single month. £18.66 cost per acquisition against a £200+ consultation value. 157% uplift in conversions versus the prior period. 50.9% improvement in conversion rate versus benchmark.

Read the full case study →

Growing Companies

Growing Diagnostics Company

Problem

First patient marketing programme. Needed to drive awareness of a diagnostic test among patients who could request it from their GP. No existing patient-facing content. Uncertain about compliance boundaries.

What we did

Legal assessment. Claims matrix. Compliant patient content. Targeted digital campaigns.

Result

Legal framework established in 6 weeks. First patient enquiries within 3 months. Participating clinics now actively promoting testing. Named reference available on the triage call.

* Some clients prefer to remain anonymised on the public site. The named reference is contactable on the triage call.

What it costs not to do this.

UK private healthcare admissions hit record highs in 2023 (PHIN), with self-pay at its highest ever level. Patients are choosing providers online, with or without the manufacturer in the conversation. Every month without a patient marketing capability is a month the clinic customers are fighting for those patients without help - and a month competitors are starting to offer it.

There is also the patient consequence. A 56-year-old with osteoarthritis finds out about a procedure from a Facebook ad rather than from the manufacturer that has spent ten years researching it. A patient whose condition could have been detected six months earlier finds the test through a friend, not through the company that built it. The cost is measured in delayed care, longer pain, worse outcomes - for the exact people the product was built to help.

Patient marketing is not a luxury layer added to a launch. For the right companies, it is the difference between an innovation that reaches the patients it was built for, and one that doesn't.

Which situation are you in?

No patient marketing yet

Competitors are hesitating. That's the opening.

Most healthcare companies are wary of patient marketing because the regulation is real. It isn't impossible. The companies that build the compliant system first own the space while the others wait.

Some activity, low conversion

Patients are finding you. They're not booking.

Awareness without action is expensive. Something is breaking between the first touchpoint and the booking. The job is to diagnose where patients are dropping off - and fix that point, not run more traffic into the same leak.

Co-marketing with clinics

You sell the product. The clinic needs the patient.

The co-marketing model: the manufacturer helps the clinic attract patients, patients arrive, the product gets used. What we build is the system and the compliance framework that lets both parties move forward without each waiting for the other.

Engagement scope by stage

What this looks like at your stage.

Founders raising investment

Investors back founders who can show a patient acquisition strategy, not just HCP dependency. Scope: legal viability assessment, patient acquisition roadmap, market sizing, co-marketing model design. Investor-ready business case included.

From £5K · 4-6 weeks

Growing companies

First patient marketing programme. Legal first, campaigns second. Establishes what's allowed, builds the compliant framework, runs the first campaigns. Scope: legal assessment, claims matrix, patient content strategy, digital campaigns, find-a-clinic, analytics dashboard.

From £8K legal foundation · £15K to £40K full programme · 6-12 months

Enterprise

Multi-market patient marketing at scale. Integrated with existing systems, built for procurement, and managed across markets. Scope: global legal framework, claims matrix, campaign strategy across markets, CRM integration, attribution dashboard, ongoing management.

From £40K · 6-18 months

Questions we hear in every triage call.

Patient marketing isn't allowed in our category.

Worth checking. The first step is a legal assessment. If it isn't viable, you'll be told in the triage call. No point wasting time on either side. But in twenty years of building these frameworks, we've rarely found a category where compliant patient marketing is genuinely impossible, though for a prescription-only medicine it means awareness of the condition, not the product. We've mostly found categories where nobody had tried properly.

Our legal team will never approve this.

Most legal teams approve patient marketing when they're given a compliant framework to evaluate, rather than a vague idea to defeat. The founder has a law degree and has built these frameworks alongside the world's largest legal firms. The legal team isn't the enemy - they're the enabler, when they're given something concrete to approve.

We don't have clinic relationships to co-market with.

Then patient marketing may not be the right first priority. Pre-revenue or no clinic customers yet means the better starting point is Product Launch Excellence - build those relationships first. Patient marketing is typically a second-stage investment.

This sounds expensive.

The legal foundation starts at £8K. The relevant comparison isn't the cost itself - it's the cost against the revenue from increased procedure volume. One engagement returned year-one procedure growth in the double digits (full numbers under NDA on the call). The programme pays for itself once patient volume moves.

How do we know it's working?

Real-time dashboards. Patient acquisition cost. Campaign-to-procedure attribution. Traffic by source, enquiries by clinic, conversion rates, cost per enquiry. Marketing that can't be measured is hopeful spending; this isn't.

Our clinics won't want to participate.

Clinics want patients. What we've seen, repeatedly, is that clinics actively request marketing support once they see the results. The co-marketing model means you're giving them something valuable - patient volume - not asking for something.

Who delivers

Strategic Lead

Michael Colling-Tuck

Law degree. Twenty years in healthcare marketing. Patient marketing frameworks built for global pharma. Worked alongside the world's largest legal firms on compliance structures. Celebrity-fronted patient campaigns approved and delivered. The legal expertise that makes everything else possible.

Research Partner

Professor Christopher Eccleston

Centre for Pain Research, University of Bath. How patients process health information. Why they delay seeking treatment. How language shifts perception. The peer-reviewed research that makes patient messaging evidence-based, not assumed.

You might also need

Ready to talk?

60-minute triage call. No fee. No pitch. Bring your situation and we’ll tell you honestly whether we can help.

Apply for a free 60 minutes with usRead the Book

See what good looks like

The two campaign-type guides most relevant to this service.

Each guide names a single buyer decision and gives an opinionated read on the right answer for healthcare. Read them before the triage call and the conversation goes faster.

Campaign-type guide

Organic social

Read the guide

Campaign-type guide

Landing pages & CTAs

Read the guide

Or browse all eight guides

Healthcare innovations deserve recognition. We help them get it.